FDA recently published a final guidance for industry to describe and answer questions about FDA’s use of remote regulatory assessments (RRAs) to oversee and assure compliance of FDA-regulated products, outside of the COVID-19 pandemic.
The UK Food Standards Agency has established a safe upper limit for THC consumed in hemp-derived CBD foods and beverages of 0.07 milligrams per day, and is encouraging businesses to reformulate CBD products in light of the new THC recommendations.
Noting that food hygiene rating schemes are already in operation in several European countries, the Food Safety Authority of Ireland is calling on consumers and food businesses to share their views through an online consultation that will run until June 23, 2025.
The updated Fifth Edition of FDA’s Food Allergen Q&A Guidance has been published in a searchable webpage format. Revisions include the addition of sesame as a major food allergen, as well as the removal of some tree nuts, including coconut, from the list of major food allergens.
The UK Food Standards Agency (FSA) has published updated industry guidance on providing written allergen information to consumers with food allergies at retail food establishments serving non-prepacked foods.
FDA has released four new guidance documents to help industry comply with food labeling regulations concerning allergens and plant-based alternatives to animal foods, as well as food safety regulations for ready-to-eat (RTE), low-moisture foods.
To assist interpretation of test results generated by UK Health Security Agency (UKHSA) microbiology laboratories, UKHSA has published new guidelines for assessing the microbiological safety of ready-to-eat (RTE) foods placed on the market.
To promote consistency in industry use of allergen quantitative risk assessment, ILSI Europe has developed a new practical guidance to help harmonize the data-gathering processes for food allergen risk assessment and aid implementation.
The European Food Safety Authority (EFSA) is seeking stakeholder input on a new draft guidance regarding the characterization and risk assessment of microorganisms used in foods.
The U.S. Food and Drug Administration (FDA) has issued a draft guidance for industry regarding the requirement to notify the agency in the case of a permanent discontinuance or an interruption of the manufacture of an infant formula product.
